HomeNews & TopicsResearchResearch team has isolated the COVID-19 virus

Research team has isolated the COVID-19 virus

Published on

A team of researchers from Sunnybrook, McMaster University and the University of Toronto has isolated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent responsible for the ongoing outbreak of COVID-19.

Thanks to nimble collaboration, the team was able to culture the virus from two clinical specimens in a Level 3 containment facility.

“We need key tools to develop solutions to this pandemic. While the immediate response is crucial, longer-term solutions come from essential research into this novel virus,” said Dr. Samira Mubareka, microbiologist and infectious diseases physician at Sunnybrook.

The isolated virus will help researchers in Canada and across the world develop better diagnostic testing, treatments and vaccines, and gain a better understanding of SARS-CoV-2 biology, evolution and clinical shedding.

“Researchers from these world-class institutions came together in a grassroots way to successfully isolate the virus in just a few short weeks,” said Dr. Rob Kozak, clinical microbiologist at Sunnybrook. “It demonstrates the amazing things that can happen when we collaborate.”

Dr. Arinjay Banerjee, NSERC post-doctoral fellow at McMaster University, said he knows the collaboration won’t stop there.

“Now that we have isolated the SARS-CoV-2 virus, we can share this with other researchers and continue this teamwork,” he said. “The more viruses that are made available in this way, the more we can learn, collaborate and share.”

Congratulations to Dr. Samira Mubareka and Dr. Rob Kozak of Sunnybrook and University of Toronto; Dr. Arinjay Banerjee and Dr. Karen Mossman of McMaster University.

 

Latest articles

A simple blood test can predict Crohn’s disease before symptoms appear

HN Summary• Sinai Health researchers have shown a simple blood test can predict Crohn’s...

Shorter duration of antimicrobial therapy in common infections

HN Summary• Growing evidence shows that shorter courses of antibiotics are just as effective...

Growing pressures facing hospital sector

At recent  2026/27 Pre-Budget Consultations, held by the Ministry of Finance in North York,...

Global clinical trial exploring potential treatment for sickle cell disease

HN Summary• SHN is leading a global clinical trial testing tebapivat, an investigational oral...

More like this

Shorter duration of antimicrobial therapy in common infections

HN Summary• Growing evidence shows that shorter courses of antibiotics are just as effective...

Global clinical trial exploring potential treatment for sickle cell disease

HN Summary• SHN is leading a global clinical trial testing tebapivat, an investigational oral...

Lithium study yields insights in the fight against HIV

Study in human cells finds low-cost drug keeps virus dormant through an unexpected pathway,...

Gene mutation in blood-forming cells may improve cancer immunotherapy results

Researchers at UHN’s Princess Margaret Cancer Centre have found that inactivation of the TET2...

Equity-focused study on immigrant kidney disease risk

HN Summary• A new SHN-led study published in BMJ Open reveals significant disparities in...

Research study makes heart screening faster, more accessible using AI

A new study from researchers at UHN unveils an AI model to analyze data...